Contributions to the Morphology of the Mistletoe (Viscum album, L.)

Antioxidant Activity of European Mistletoe (Viscum album)

Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.

BACKGROUND Medulloblastoma constitute more than 20% of all paediatric brain tumours and are the most common malignant brain tumours in children. Adjuvant chemotherapy has seen a strong increase in the use of complementary medicine for cancer treatment. Evidence for cytotoxic and apoptotic effects of Viscum album (Mistletoe) in vitro is available, however, no data concerning paediatric tumours, ...

Immunologic Response to Mistletoe Extract (Viscum album L.) after Conventional Treatment in Patients with Operable Breast

During treatment of cancer, some side effects of conventional treatment may limit the ability of the patient to receive the full course of therapy. To reduce the side effects and improve the effectiveness of standard therapy, many complementary or alternative medicines (CAM) have been tried in patient with a variety of cancers. Mistletoe extracts are among commonly prescribed CAM for cancer pat...

Intrapleural Instillation of a Viscum album (L.) Extract (Mistletoe) for the Treatment of Malignant Pleural Effusions

Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.

European mistletoe (Viscum album) has been used in complementary cancer treatment, but little is known concerning its effects on immunological parameters, although there is evidence that Viscum may stimulate the immune system. In this study, a trial was conducted with cancer patients to determine whether Viscum album extracts could improve the results of immune tests. These were: white blood ce...